Want to join the conversation?
In 4Q16, $MLHR had orders of $606MM, up 9% from 4Q15. Sales in the North American segment were $333MM, up 8% from last year. New orders rose 11.5%. ELA segment reported sales of $111MM, up 7% from last year. New orders rose 8.9%. Specialty sales were $62MM, up almost 4%. New orders rose 7%. Consumer sales were $78MM, down 2% from last year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.